Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0 Views
administrator
07/04/23
Earn CME for related activities: https://www.naccme.com/oln
This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.
ยฉ 2018 NACCME, an HMP Company
-
Category
Show more
Facebook Comments
No comments found